# Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer

> **NCT00868491** · PHASE2 · COMPLETED · sponsor: **Institute of Oncology Ljubljana** · enrollment: 30 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** docetaxel, cisplatin, 5-fluorouracil
- **RADIATION:** radiotherapy
- **DRUG:** cetuximab, cisplatin

## Key facts

- **NCT ID:** NCT00868491
- **Lead sponsor:** Institute of Oncology Ljubljana
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-12
- **Final completion:** 2011-10-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00868491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00868491, "Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00868491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*